AZN icon

AstraZeneca

1,138 hedge funds and large institutions have $33.8B invested in AstraZeneca in 2024 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 485 increasing their positions, 340 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

0.45% less ownership

Funds ownership: 32.57%32.12% (-0.45%)

1% less capital invested

Capital invested by funds: $34B → $33.8B (-$235M)

8% less funds holding in top 10

Funds holding in top 10: 1312 (-1)

Holders
1,138
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$480M
Puts
$470M
Net Calls
Net Calls Change

Top Sellers

1 -$903M
2 -$659M
3 -$157M
4
N
Nuveen
North Carolina
-$129M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$103M
Name Holding Trade Value Shares
Change
Change in
Stake
751
$324K
752
$323K
753
$323K
754
$323K
755
$322K
756
$320K
757
$318K
758
$317K
759
$316K
760
$316K
761
$315K
762
$315K
763
$315K
764
$315K
765
$314K
766
$314K
767
$313K
768
$313K
769
$312K
770
$310K
771
$310K
772
$309K
773
$307K
774
$307K
775
$305K